ECOR
HEALTHCAREElectroCore Inc
$6.66-0.33 (-4.72%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ECOR Today?
No stock-specific AI insight has been generated for ECOR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.16$8.64
$6.66
Fundamentals
Market Cap$54M
P/E Ratio—
EPS$-1.65
Dividend Yield—
Dividend / Share—
ROE-4.8%
Profit Margin-0.4%
Debt / Equity—
Trading
Volume19K
Avg Volume (10D)—
Shares Outstanding8.1M
ECOR News
21 articles- electroCore to Present at LD Micro Invitational XVI Conference on May 18, 2026GeneOnline·May 9, 2026
- electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026GlobeNewswire Inc.·May 9, 2026
- electroCore (ECOR) Q1 2026 Earnings TranscriptMotley Fool·May 7, 2026
- electroCore, Inc. Q1 2026 Earnings Call SummaryMoby·May 7, 2026
- electroCore Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- electroCore Announces First Quarter 2026 Financial ResultsYahoo Finance·May 6, 2026
- electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero ChallengeYahoo Finance·Apr 30, 2026
- electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026Yahoo Finance·Apr 29, 2026
- electroCore to Present at the Market Movers Investor Summit on May 5, 2026GlobeNewswire Inc.·Apr 28, 2026
- electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve StimulationYahoo Finance·Apr 23, 2026
- Ecora Resources Calls 2025 a “Landmark Year” as Critical Minerals Top 50% and Debt FallsMarketbeat·Apr 14, 2026
- How The Ecora Royalties (LSE:ECOR) Narrative Is Shifting As Analyst Views DivergeYahoo Finance·Apr 11, 2026
- electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?Yahoo Finance·Apr 10, 2026
- electroCore to Participate in the 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Apr 8, 2026
- Ecora Royalties PLC Announces Investor Presentation via Engage InvestorYahoo Finance·Apr 7, 2026
- electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSDYahoo Finance·Apr 7, 2026
- Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?Yahoo Finance·Apr 6, 2026
- electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSDGlobeNewswire Inc.·Apr 1, 2026
- electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Yahoo Finance·Mar 31, 2026
- electroCore Expands Intellectual Property PortfolioYahoo Finance·Mar 30, 2026
All 21 articles loaded
Price Data
Open$0.00
Previous Close$6.99
Day High$0.00
Day Low$0.00
52 Week High$8.64
52 Week Low$4.16
52-Week Range
$4.16$8.64
$6.66
Fundamentals
Market Cap$54M
P/E Ratio—
EPS$-1.65
Dividend Yield—
Dividend / Share—
ROE-4.8%
Profit Margin-0.4%
Debt / Equity—
Trading
Volume19K
Avg Volume (10D)—
Shares Outstanding8.1M
About ElectroCore Inc
electroCore, Inc., a commercial-stage medical device company, is dedicated to the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is headquartered in Rockaway, New Jersey.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—